Lars H. Lund
0000-0003-1411-4482
11 papers found
Refreshing results…
Epidemiology, Clinical Characteristics and Cause-specific Outcomes in Heart Failure with Preserved Ejection Fraction
Global Public Health Burden of Heart Failure: An Updated Review
A machine learning model for prediction of 30-day primary graft failure after heart transplantation
Persistent High Burden of Heart Failure Across the Ejection Fraction Spectrum in a Nationwide Setting
Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial
Association between dosing and combination use of medications and outcomes in heart failure with reduced ejection fraction: data from the Swedish Heart Failure Registry
Atrial disease and heart failure: the common soil hypothesis proposed by the Heart Failure Association of the European Society of Cardiology
Implementation science and potential for screening in heart failure
Cardiovascular effects of non-insulin glucose-lowering agents: a comprehensive review of trial evidence and potential cardioprotective mechanisms
Predictors of long‐term outcome in heart failure with preserved ejection fraction: a follow‐up from the KaRen study
Empagliflozin in Heart Failure With Predicted Preserved Versus Reduced Ejection Fraction: Data From the EMPA-REG OUTCOME Trial
Missing publications? Search for publications with a matching author name.